Serina Therapeutics SER
NYSE SER
$2.87 +0.22 (+8.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

Serina Therapeutics (SER) Gross Margin Growth (1y) (2019 - 2023)

Serina Therapeutics (SER) Gross Margin Growth (1y) (2019 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -91.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 210.00
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1,966.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 228.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -475.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3,672.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1,034.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Serina Therapeutics 46.70 Mn 23.67 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -8,572.00
Sep 30, 2023 7,280.00
Jun 30, 2023 714.00
Mar 31, 2023 -5,000.00
Dec 31, 2022 7,125.00
Sep 30, 2022 -4,722.00
Jun 30, 2022 -1,486.00
Mar 31, 2022 -1,464.00
Dec 31, 2021 -8,059.00
Sep 30, 2021 1,630.00
Jun 30, 2021 -2,847.00
Mar 31, 2021 -423.00
Dec 31, 2020 1,123.00
Sep 30, 2020 -1,272.00
Jun 30, 2020 728.00
Mar 31, 2020 1,511.00
Dec 31, 2019 2,650.00
Sep 30, 2019 -1,297.00
Jun 30, 2019 308.00